[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19185]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07627]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
PS16-003, Evaluating Locally-Developed or Adapted (Homegrown) 
Combination HIV Prevention Interventions for Transgender Persons who 
have Sex with Men; and FOA PS16-004, Increase Access to Care for Black 
Men Who Have Sex with Men.
    Time and Date: 10:00 a.m.-5:00 p.m., EDT, April 26-27, 2016 
(Closed)
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Evaluating Locally-Developed or Adapted Combination HIV Prevention 
Interventions for Transgender Persons who have Sex with Men'', FOA 
PS16-003; and ``Increase Access to Care for Black Men Who Have Sex with 
Men'', FOA PS16-004.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-07627 Filed 4-1-16; 8:45 am]
 BILLING CODE 4163-18-P